发明名称 Salmonid alphavirus vaccine
摘要 <p>A vaccine or immunogenic composition comprises an inactivated salmonid alphavirus, with a titre of at least 7.5x108 TCID50/ml, combined with one or more components selected from the group consisting of: a killed or inactivated bacterium, an inactivated virus other than salmonid alphavirus, a fungus, a parasite; or an antigenic and/or immunogenic material derived from any of these components. The salmonid alphavirus is preferably derived from the SAV1, SAV2 or SAV3 subtypes. Other components of the vaccine may be directed against Aeromonas salmonicida, Aeromonas hydrophila, Vibrio salmonicida, Vibrio anguillarum 01 and/or 02, Vibrio ordali, Moritella viscosa, Flavobacterium columnaris, Haphnia spp., Piscirickettsia salmonis, and/or infectious pancreatic necrosis virus (IPNV).</p>
申请公布号 GB2493662(B) 申请公布日期 2013.04.17
申请号 GB20120019654 申请日期 2009.02.06
申请人 PHARMAQ AS 发明人 SVEIN ALEXANDERSEN;TRYGVE MEUM ELIASSEN;INGE TOM SOLBAKK;MARIT RODE;BERNT MARTINSEN;ANNE AAS-ENG
分类号 A61K39/12;A61K39/295;A61P31/14;C12N7/00;C12N7/02 主分类号 A61K39/12
代理机构 代理人
主权项
地址